Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer

Clinical trial NCT01050842 · COMPLETED

Trial details

NCT number: NCT01050842
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Adenocarcinoma of the Prostate Hormone-resistant Prostate Cancer Stage IV Prostate Cancer

Start date: 2010-02-01
Primary completion: 2012-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.